A revolutionary therapeutic approach for psoriasis: bispecific biological agents

Expert Opin Investig Drugs. 2016 Jul;25(7):751-4. doi: 10.1080/13543784.2016.1187130. Epub 2016 May 23.

Authors

T Torres¹, M Romanelli², A Chiricozzi²

Affiliations

¹ a Department of Dermatology, Centro Hospitalar do Porto and Instituto de Ciências Biomédicas Abel Salazar , University of Porto , Porto , Portugal.
² b Dermatology Department , University of Pisa , Pisa , Italy.

PMID: 27153320
DOI: 10.1080/13543784.2016.1187130

No abstract available

Keywords: ABT-122; ALX-0761; AZ17; Bimekizumab; COVA322; Psoriasis; bispecific antibodies.

Publication types

Editorial

MeSH terms

Antibodies, Bispecific / therapeutic use*
Biological Factors / therapeutic use*
Humans
Psoriasis / immunology
Psoriasis / therapy*

Substances

Antibodies, Bispecific
Biological Factors